Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study

Fig. 2

Spectrum of detected actionable genetic alterations. (A-B) Bar chart showing the fraction of actionable mutations per cancer entity (A) and ten most frequent actionable genetic alterations (B), as assessed and classified using the OncoKB database. (C-D) Bar chart showing the fraction of actionable mutations per cancer entity (C) and all actionable genetic alterations (D), as assessed by the EMSO treatment guidelines for gastrointestinal, hepato- and pancreaticobiliary cancers and classified by the ESCAT score

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us